Covalon Technologies Ltd.
405 Britannia Road East
Suite 106
Mississauga
Ontario
L4Z 3E6
Canada
Tel: 905-568-8400
Fax: 905-568-5200
Website: http://www.covalon.com/
Email: office@covalon.com
187 articles about Covalon Technologies Ltd.
-
Covalon Announces Voting Results from 2019 Annual and Special Meeting of Shareholders
3/8/2019
Covalon Technologies Ltd., an advanced medical technologies company, announces the results of the matters voted upon at the Company’s 2019 Annual and Special Meeting of Shareholders on held March 7, 2019.
-
Covalon Announces Conference Call to Discuss First Quarter Financial Results
2/21/2019
Covalon Technologies Ltd., an advanced medical technologies company, will be releasing its Fiscal 2019 First Quarter financial results on Tuesday February 26th, 2019, after markets close.
-
Mr. John Suk Joins Covalon’s Board of Directors
1/30/2019
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. John Suk has joined Covalon’s Board of Directors.
-
Covalon Announces Change of Auditors and Amends and Restates Its Rolling Stock Option Plan
1/24/2019
Covalon Technologies Ltd. announced that it has appointed PricewaterhouseCoopers LLP (“Successor Auditor”) as its auditor.
-
Covalon Announces Issuance of 2018 Stock Options
12/27/2018
The stock options will vest over three years and will be exercisable for a period of five years at an exercise price of $4.28 per stock option.
-
Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results
12/17/2018
A conference call to discuss the financial results will be held Tuesday December 18th, 2018, at 9:00am EST.
-
Covalon Announces Fiscal 2018 Year-End Results and Plans for Fiscal 2019
12/17/2018
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces its fiscal 2018 year-end results and plans for fiscal 2019.
-
Covalon Announces Successful Completion of Operational Integration of AquaGuard Acquisition amid Continued Business Progress
10/30/2018
Covalon Technologies Ltd. today announces that it has successfully completed the integration of AquaGuard with its operations.
-
Covalon to Showcase AquaGuard® and IV Clear™ Products to Over 9,000 Nurses at Prestigious ANCC Magnet Conference
10/24/2018
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV) (OTCQX:CVALF), an advanced medical technologies company, today announces that it will be showcasing newly-acquired moisture barrier line AquaGuard® as part of its portfolio of infection prevention products at the 2018 American Nurses Credentialing Center National Magnet Conference
-
Covalon Announces Closing of AquaGuard Acquisition Combining Covalon’s Rich Technology Portfolio with AquaGuard’s Excellent Products and Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States
10/1/2018
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has closed the acquisition (the “Closing”) of AquaGuard, the Seattle, Washington-based division of medical technologies company Cenorin, LLC
-
Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States
9/20/2018
Covalon Technologies Ltd. today announces that it has entered into a definitive agreement to acquire AquaGuard, the Seattle, Washington-based division of medical technologies company Cenorin, LLC.
-
Covalon to Showcase IV Clear at AVA Scientific Meeting 2018
9/14/2018
Covalon Technologies Ltd. today announces that it will be showcasing IV Clear at the 2018 Scientific Meeting for the Association for Vascular Access
-
Covalon Announces Another Milestone Quarterly Profit on Excellent Third Quarter Financial Results
8/28/2018
Covalon Technologies Ltd. is pleased to announce today another milestone quarterly profit of $2.2 million on excellent third quarter financial results.
-
Covalon Announces Receipt of First Payment Under New License Agreement
8/20/2018
The Agreement provides the Medical Partner with certain rights to use Covalon’s patented antimicrobial medical coating technology with some of its devices.
-
Covalon Announces Major Banking Milestone
8/9/2018
New $17 million acquisition and operating banking facility with major international bank HSBC and Export Development Canada.
-
Covalon Announces Retirement of Member of Board of Directors
7/26/2018
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces that Martin Bernholtz has retired as a member of the Board of Directors of the Company, effective at the end of this month, on July 31st 2018.
-
Covalon Technologies Ltd. to Exhibit at the Largest Annual Infection Prevention and Control Conference in the World
6/12/2018
APIC 2018 Conference in Minneapolis, Minnesota, June 13th to 15th.
-
Covalon Provides Further Information Regarding Estimated $100 Million Competitive Contract Awards
5/22/2018
Covalon wins every single Vascular Access dressing category for the next three years in the Gulf Cooperation Council States in the Middle East
-
Covalon Announces Major Sales Breakthrough – Wins Contracts with an Estimated Value of $100 Million Over a Three-Year Period
5/7/2018
Conference call scheduled for Tuesday May 8th at 9am EDT to discuss the impact of this major transformative event
-
Covalon to Showcase MediClear™ PreOp at AATS 2018 Annual Meeting
4/30/2018
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be showcasing its perioperative suite of innovative products, including MediClear™ PreOp, at the American Association for Thoracic Surgery (“AATS”) Annual Meeting